Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant

Environmental Research

Volumn 127, Issue , 2013, Pages 22-28

  Simpson, Chris ^a   Winquist, Andrea ^a   Lally, Cathy ^a   Steenland, Kyle ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Cerebrovascular accident; Cohort study; Perfluorooctanoic acid; PFOA; Stroke

Indexed keywords

PERFLUOROOCTANOIC ACID;

CARBOXYLIC ACID; CHEMICAL INDUSTRY; COHORT ANALYSIS; CONFIDENCE INTERVAL; DRINKING WATER; HEALTH RISK; HYPERTENSION; MORTALITY; POLLUTION EXPOSURE; SERUM; STROKE;

ADULT; ARTICLE; BLOOD LEVEL; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSIENT ISCHEMIC ATTACK; WORKER;

CEREBROVASCULAR ACCIDENT; COHORT STUDY; PERFLUOROOCTANOIC ACID; PFOA; STROKE;

AGED; CAPRYLATES; CHEMICAL INDUSTRY; COHORT STUDIES; CONFIDENCE INTERVALS; DRINKING WATER; ENVIRONMENTAL EXPOSURE; FEMALE; FLUOROCARBONS; HUMANS; MALE; MIDDLE AGED; STROKE; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION;

EID: 84888378338     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2013.10.002     Document Type: Article

References (30)

1. Applebaum K.M., Malloy E.J., Eisen E.A. Left truncation, susceptibility, and bias in occupational cohort studies. Epidemiology 2011, 22(4):599-606.
2. Bartell S.M., Calafat A.M., Lyu C., Kato K., Ryan P.B., Steenland K. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ. Health Perspect. 2010, 118(2):222-228.
3. Brede E., Wilhelm M., Goen T., Muller J., Rauchfuss K., Kraft M., et al. Two-year follow-up biomonitoring pilot study of residents' and controls' PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int. J. Hyg. Environ. Health 2010, 213(3):217-223.
4. Calafat A.M., Wong L.Y., Kuklenyik Z., Reidy J.A., Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 2007, 115:1596-1602.
5. Costa G., Sartori S., Consonni D. Thirty years of medical surveillance in perfluooctanoic acid production workers. J. Occup. Environ. Med. 2009, 51:364-372.
6. Emmett E.A., Shofer F.S., Zhang H., Freeman D., Desai C., Shaw L.M. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J. Occup. Environ. Med. 2006, 48(8):759-770.
7. Feig D.I., Soletsky B., Johnson R.J. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008, 300(8):924-932.
8. Frisbee S.J., Brooks A.P., Maher A., Flensborg P., Arnold S., Fletcher T., et al. The C8 health project: design, methods, and participants. Environ. Health Perspect. 2009, 117(12):1873-1882.
9. Fromme H., Tittlemier S.A., Völkel W., Wilhelm M., Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270.
10. Goncharov A., Pavuk M., Foushee H.R., Carpenter D.O. Blood pressure in relation to concentrations of PCB congeners and chlorinated pesticides. Environ. Health Perspect. 2011, 119:319-325.
11. Houde M., Martin J.W., Letcher R.J., Solomon K.R., Muir D.C.G. Biological monitoring of polyfluoroalkyl substances: a review. Environ. Sci. Technol. 2006, 40(11):3463-3473.
12. Kannan K., Corsolini S., Falandysz J., Fillmann G., Kumar K.S., Loganathan B.G., et al. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol. 2004, 38:4489-4495.
13. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
14. Lee D.H., Steffes M.W., Sjödin A., Jones R.S., Needham L.L., Jacobs D.R. Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study. Environ. Health Perspect. 2010, 118:1235-1242.
15. Leonard R.C., Kreckmann K.H., Sakr C.J., Symons J.M. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann. Epidemiol. 2008, 18:15-22.
16. Lundin J.I., Alexander B.H., Olsen G.W., Church T.R. Ammonium perfluorooctanoate production and occupational mortality. Epidemiology 2009, 20(6):921-928.
17. Min J.-Y., Lee K.-J., Park J.-B., Min K.-B. Perfluorooctanoic acid exposure is associated with elevated homocysteine and hypertension in US adults. Occup. Environ. Med. 2012, (Published Online First: 31 May 2012). 10.1136/oemed-2011-100288.
18. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115(9):1298-1305.
19. Piechowski-Józwiak B., Bogousslavsky J. Cholesterol as a risk factor for stroke: the fugitive?. Stroke 2004, 35:1523-1524.
20. Sakr C.J., Kreckmann K.H., Green J.W., Gillies P.J., Reynolds J.L., Leonard R.C. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J. Occup. Environ. Med. 2007, 49:1086-1096.
21. Shankar A., Klein R., Klein B.E., Nieto F.J. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J. Hum. Hypertens. 2006, 20(12):937-945.
22. Shankar A., Xiao J., Ducatman A. Perfluoroalkyl chemicals and elevated serum uric acid in US adults. Clin. Epidemiol. 2011, 3:251-258.
23. Shin H.M., Vieira V.M., Ryan P.B., Detwiler R., Sanders B., Steenland K., et al. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works facility in West Virginia. Environ. Sci. Technol. 2011, 45(4):1435-1442.
24. Shin H.M., Vieira V.M., Ryan P.B., Steenland K., Bartell S.M. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ. Health Perspect. 2011, 119(12):1760-1765.
25. Steenland K., Deddens J.A. A practical guide to dose-response analyses and risk assessment in occupational epidemiology. Epidemiology 2004, 15(1):63-70.
26. Steenland K., Fletcher T., Savitz D.A. Epidemiologic evidence on the health effects of perflurooctanoic acid (PFOA). Environ. Health Perspect. 2010, 118(8):1100-1108.
27. Steenland K., Tinker S., Shankar A., Ducatman A. Association of perfluorooctanic acid (PFOA) and perfluorooctanesulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ. Health Perspect. 2010, 118:229-233.
28. Tirschwell D.L., Smith N.L., Heckbert S.R., Lemaitre R.N., Longstreth W.T., Psaty B.M. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 2004, 63:1868-1875.
29. Winquist A., Lally C., Shin H.M., Steenland K. Design, methods and population for a study of PFOA health effects among highly exposed Mid-Ohio Valley community residents and workers. Environ. Health Perspect. 2013, 121:893-899.
30. Woskie S.R., Gore R., Steenland K. Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant. Ann. Occup. Hyg. 2012, 56(9):1025-1037.